, Tracking Stock Market Picks
Enter Symbol:
Rating: MS
Buy $35
down 21.00 %

Morgan Stanley (NYSE: MS) reiterated to Buy with price target $35 by Argus

Tuesday,  Jan 19, 2016  3:25 PM ET by Betsy O'Brien Harrison

Argus reiterated Morgan Stanley (NYSE: MS) to Buy with price target $35. Previously Argus reiterated Morgan Stanley (NYSE: MS) to Buy with price target
$40 on 09/04/2015, when the stock price was $33.24. Since then, Morgan Stanley's stock price has lost 21% as of 01/19/2016's recent price of $26.29.
If you would have followed the previous Argus's recommendation on MS, you would have lost 21% of your investment in 137 days.

Morgan Stanley is a global financial services firm that, through its subsidiaries and affiliates, provides its products and services to a group of clients and customers, including corporations, governments, financial institutions and individuals. The Company operates in three segments: Institutional Securities, Global Wealth Management Group and Asset Management. On October 14, 2008, Mitsubishi UFJ Financial Group, Inc. acquired a 21% stake in Morgan Stanley. Institutional Securities' services includes capital raising; financial advisory services, including advice on mergers and acquisitions, restructurings, real estate and project finance. Global Wealth Management Group's services include brokerage and investment advisory services covering various investment alternatives; financial and wealth planning services, and annuity and other insurance products. Asset Management's services include global asset management products and services in equity, fixed income, alternative investments.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy